SOURCE: Progressive Care Inc.

Progressive Care Inc.

November 24, 2015 08:00 ET

Progressive Care Inc. Reports Positive Response From New York Road Show

MIAMI, FL--(Marketwired - November 24, 2015) - Progressive Care Inc. (OTC PINK: RXMD), through its subsidiary Pharmco LLC, a South Florida provider of prescription pharmaceuticals specializing in health practice risk management, the sale of anti-retroviral medications and related medication therapy management, the sale and rental of durable medical equipment ("DME") and the supply of prescription medications to long term care facilities, announces results from its recent non-deal road show in New York City.

Progressive Care presented the company late last week, showcasing the many milestones hit throughout the 2015-year. The road show participants were pleased with the ongoing development of the Company namely the establishment of the PharmCo brand, the improvements to its financial position, and the imminent completion of the 3(a)(10) transaction.

Shital Parikh Mars stated, "It was a very busy week in preparation for the deployment of this non-deal road show. This was the first road show the company has done and I'm happy to report that we received exceptionally favorable responses. It is just another testament to the company's goal of continuing to build real shareholder value through our current business model and we're looking forward to building a lasting relationship with the investment community."

In addition, the Company recently issued what it believes to be its final tranche of shares to Tarpon Bay for completion of its 3(a)(10) transaction. Progressive recently reported positive results from operations during the month of October and highlighted the increased demand from its compounding business. Management expects to provide an update during the first half of December on this month's operational performance as well as an update on the status of the 3(a)(10) transaction.

About Progressive Care

Progressive Care Inc. (OTC PINK: RXMD), through its subsidiary PharmCo, LLC, is a South Florida provider of prescription pharmaceuticals specializing in health practice risk management, the sale of anti-retroviral medications and related medication therapy management, the sale and rental of durable medical equipment and the supply of prescription medications to long term care facilities.

Cautionary Statement Regarding Forward Looking Statements

Statements contained herein that are not based upon current or historical fact are forward-looking in nature and constitute forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Such forward-looking statements reflect the Company's expectations about its future operating results, performance and opportunities that involve substantial risks and uncertainties. These statements include but are not limited to statements regarding the intended terms of the offering, closing of the offering and use of any proceeds from the offering. When used herein, the words "anticipate," "believe," "estimate," "upcoming," "plan," "target", "intend" and "expect" and similar expressions, as they relate to Progressive Care Inc., its subsidiaries, or its management, are intended to identify such forward-looking statements. These forward-looking statements are based on information currently available to the Company and are subject to a number of risks, uncertainties, and other factors that could cause the Company's actual results, performance, prospects, and opportunities to differ materially from those expressed in, or implied by, these forward-looking statements.